Venture Capital Firm Based Out of Massachusetts Institute of Technology is Bringing Risky Back
Anyone can easily acknowledge the severity of major problems in today’s society, but only a fraction of people dedicate time and effort to formulating a plausible solution. Especially given the current pandemic, it is evident that biotechnology needs to be improved to provide quicker responses to infectious diseases that threaten society. Another example would be the media often reporting that the Earth’s average temperature is rising and needs to be controlled to ensure livable conditions for future generations but attempting to solve such complex problems realistically takes time, people, and a lot of money.
